Medicare Enrolled
Dr. Julio Andino-Velez, M.D.
Neurology · Rockwall, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Andino-Velez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Andino-Velez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Andino-Velez
Dr. Julio Andino-Velez is a neurology specialist in Rockwall, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Andino-Velez performed 3,408 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Andino-Velez received a total of $4,092 from 37 pharmaceutical and/or device companies across 286 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Andino-Velez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 15% volume in TX
$4,092 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,408
Medicare services
Top 15% in TX for neurology
Not available
Unique patients (not deduplicated)
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
933 | $93 | $297 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
282 | $59 | $198 |
| New patient office visit, complex (60-74 min) | 219 | $166 | $505 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
195 | $10 | $30 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 161 | $194 | $500 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
150 | $209 | $590 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
149 | $100 | $302 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
149 | $25 | $87 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
146 | $289 | $890 |
| Auditory brainstem response test A test that measures how the brain responds to sound to help diagnose nervous system disorders. The results are interpreted and reported by a medical professional. |
144 | $65 | $150 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
137 | $50 | $155 |
| Extended office visit by clinical staff, first hour An extended office or outpatient visit provided by clinical staff lasting at least one hour. |
131 | $14 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
124 | $127 | $415 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
82 | $65 | $210 |
| Annual depression screening | 82 | $18 | $40 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
80 | $3 | $25 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
72 | $74 | $266 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
48 | $97 | $305 |
| Autonomic nervous system testing with tilt This test evaluates the function of the sympathetic and parasympathetic nervous systems. It involves monitoring the patient for at least five minutes while they are tilted. |
47 | $112 | $346 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
46 | $94 | $307 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
16 | $162 | $586 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
15 | $219 | $787 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,092
Total received (2018-2024)
Avg $585/year across 7 years
Top 43% in TX for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
286
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$962
2023
$735
2022
$240
2021
$235
2020
$477
2019
$676
2018
$766
Payments by company (2024)
ABBVIE INC.
$246
UCB, Inc.
$213
Eisai Inc.
$118
Abbott Laboratories
$109
MDD US Operations, LLC
$101
Amneal Pharmaceuticals LLC
$52
SK Life Science, Inc.
$39
Lundbeck LLC
$26
Neurocrine Biosciences, Inc.
$25
Lilly USA, LLC
$18
Currax Pharmaceuticals LLC
$14
Top 3 companies account for 60.1% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$527
SK Life Science, Inc.
$462
ABBVIE INC.
$426
Amgen Inc.
$328
AbbVie Inc.
$265
US WorldMeds, LLC
$177
Abbott Laboratories
$161
Corium, LLC
$133
Sumitomo Pharma America, Inc.
$133
Supernus Pharmaceuticals, Inc.
$130
ACADIA Pharmaceuticals Inc
$122
Eisai Inc.
$118
MDD US Operations, LLC
$101
Biogen, Inc.
$101
Sunovion Pharmaceuticals Inc.
$88
Amneal Pharmaceuticals LLC
$83
GE Healthcare
$78
Avanir Pharmaceuticals, Inc.
$66
Novartis Pharmaceuticals Corporation
$62
Lilly USA, LLC
$60
EMD Serono, Inc.
$56
Adamas Pharmaceuticals, Inc.
$53
GENZYME CORPORATION
$51
Allergan Inc.
$47
Teva Pharmaceuticals USA, Inc.
$39
Currax Pharmaceuticals LLC
$27
Lundbeck LLC
$26
Neurocrine Biosciences, Inc.
$25
Almatica Pharma LLC
$21
Acorda Therapeutics, Inc
$21
Endo Pharmaceuticals Inc.
$20
Aprecia Pharmaceuticals, LLC
$17
GE HEALTHCARE
$15
Egalet US Inc
$15
Zyla Life Sciences, Inc.
$14
Impax Laboratories, Inc.
$12
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 34.6% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · APOKYN · APTIOM · AUBAGIO · Adlarity · Aimovig · BOTOX · Briviact · COPAXONE · Cenobamate · EMGALITY · GILENYA · GOCOVRI · GRALISE · Gocovri · INBRIJA · INFINITY · INGREZZA · LEMTRADA · Leqembi · MAYZENT · Mavenclad · NAMZARIC · NASCOBAL · NUEDEXTA · NUPLAZID · Neupro · ONZETRA XSAIL · OXTELLAR XR · QULIPTA · REXULTI · RYTARY · Rebif · SPRIX · Spritam · TROKENDI XR · TYSABRI · UBRELVY · VUMERITY · Vimpat · XARELTO · Xadago
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
159
County median income
$124,917
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL ROCKWALL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Andino-Velez is a clinical cardiology specialist, with above-average Medicare volume (top 15% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Andino-Velez experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Andino-Velez performed 933 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Andino-Velez receive payments from pharmaceutical companies?
Yes. Dr. Andino-Velez received a total of $4,092 from 37 companies across 286 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Andino-Velez's costs compare to other neurologists in Rockwall?
Dr. Andino-Velez's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Andino-Velez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Rockwall
Browse neurologists in Rockwall ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology